Evidence map›Paper›PMID 25059435›Full record

ArticleUltrasonics2014

The behavior of lipid debris left on cell surfaces from microbubble based ultrasound molecular imaging.

Stuart Ibsen, Guixin Shi, Carolyn Schutt, Linda Shi, Kyle-David Suico, Michael Benchimol, Viviana Serra, Dmitri Simberg, Michael Berns, Sadik Esener

Open access · greenAbstract read
In one paragraph

Article in Ultrasonics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Stuart IbsenDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA. Electronic address: sibsen@ucsd.edu.
Guixin ShiMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Carolyn SchuttDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA.
Linda ShiDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA.
Kyle-David SuicoDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA.
Michael BenchimolMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Viviana SerraDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA.
Dmitri SimbergMoores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Michael BernsDepartment of Bioengineering, Moores Cancer Center, University of California San Diego, 3855 Health Sciences Dr. # 0815, La Jolla, CA 92093-0815, USA.
Sadik EsenerDepartment of Nanoengineering, Moores Cancer Center, University of California at San Diego, La Jolla, CA 92093, USA.
University of California, San Diego · USMoores Cancer Center

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Tumor Therapy/Annihilation Using a Smart NanoPlatform (SNaP)U54CA119335 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESENER, SADIK · 2005 to 2010
$21.2M
UCSD Cancer Center Training Program in Drug DevelopmentT32CA121938 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Michael Bouvet, Dwayne G. Stupack · 2006 to 2026
$10.3M
UCSD Cancer Nanotechnology Training CenterR25CA153915 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUMMEL, ANDREW CLYDE, MATTREY, ROBERT F · 2010 to 2014
$1.8M
NCI NIH HHS 5U54CA119335-05NCI NIH HHS P30 CA023100NCI NIH HHS P30 CA23100NCI NIH HHS R25 CA153915NCI NIH HHS T32 CA121938NCI NIH HHS U54 CA119335
6 · The paper itself

Abstract

Lipid monolayer coated microbubbles are currently being developed to identify vascular regions that express certain surface proteins as part of the new technique of ultrasound molecular imaging. The microbubbles are functionalized with targeting ligands which bind to the desired cells holding the microbubbles in place as the remaining unbound microbubbles are eliminated from circulation. Subsequent scanning with ultrasound can detect the highly reflectant microbubbles that are left behind. The ultrasound scanning and detection process results in the destruction of the microbubble, creating lipid fragments from the monolayer. Here we demonstrate that microbubbles targeted to 4T1 murine breast cancer cells and human umbilical cord endothelial cells leave behind adhered fragments of the lipid monolayer after exposure to ultrasound with peak negative pressures of 0.18 and 0.8MPa. Most of the observed fragments were large enough to be resistant to receptor mediated endocytosis. The fragments were not observed to incorporate into the lipid membrane of the cell over a period of 96min. They were not observed to break into smaller pieces or significantly change shape but they were observed to undergo translation and rotation across the cell surface as the cells migrated over the substrate. These large fragments will apparently remain on the surface of the targeted cells for significant periods of time and need to be considered for their potential effects on blood flow through the microcapillaries and potential for immune system recognition.

Indexed as

Cell MembraneMicrobubblesUltrasonicsAntigens, NeoplasmCell Adhesion MoleculesCell Culture TechniquesEndothelium, VascularEpithelial Cell Adhesion MoleculeEquipment DesignHumansLecithinsLipidsMembrane ProteinsMicroscopy, FluorescenceMolecular ImagingPeptides, Cyclic1,2-distearoyllecithinAntigens, NeoplasmCell Adhesion Moleculescyclic arginine-glycine-aspartic acid peptideEPCAM protein, humanEpithelial Cell Adhesion MoleculeLecithinsLipidsMembrane ProteinsPEG 40 monostearatePeptides, CyclicPhosphatidylcholinesPhosphatidylethanolaminespolyethylene glycol-distearoylphosphatidylethanolaminePolyethylene GlycolsLipid debrisMicrobubbleMicrobubble targetingUltrasound molecular imaging

Identifiers

PMID25059435
PMCPMC4151124
OpenAlexW2026159608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.